February 20th, 2009

Podcast 31: Making your clinical life easier — with genetics. Dr. Julie Johnson talks about using a patient’s genetic profile to help set their initial warfarin dose more accurately. You got a problem with that?

(1 votes, average: 2.00 out of 5)

Starting a patient on warfarin is nobody’s idea of a good time, but pharmacogenetic research can help. A study in this week’s NEJM shows the advantage of using genetic information (plus some clinical data) over the old “start at 5 mg a day and pray for success” approach. We talk with Julie Johnson of the University of Florida about the study.

We’ve shortened our news presentation, on the theory that you can’t assimilate too many details through your ears, so we give you the aural cartoon version and provide links for details at the website: podcasts.jwatch.org.

If you want to contact us with your suggestions, please call 1 617 440 4374.

Links for this edition:

One Response to “Podcast 31: Making your clinical life easier — with genetics. Dr. Julie Johnson talks about using a patient’s genetic profile to help set their initial warfarin dose more accurately. You got a problem with that?”

  1. donald e stanley says:

    Moderator ought to make questions sharper.

    He should speak more clearly-there is a lisp-like overtone to his voice that prevents hearing the higher vocals.

    Emphasize the controversies rather than the main message i.e. examine the editorial in this context.

Clinical Conversations

About the Podcast

To subscribe: Subscribe on iTunes

To have your comment included in a future podcast, call 617-440-4374. Please leave your name, number, and the podcast ID number.